EventHealthNovember 5, 2026

Potential Sciences uses simulated data to skip lab work in drug design

Read original source →wired.com

The UK startup launched November 5 with seed funding in the tens of millions from SovAI, the UK government's AI venture fund, and Twin Path Ventures; exact figure undisclosed. It simulates atomic and protein interactions to build chemical datasets for training drug-binding predictors.

People · Hatem Helal

1 source

More stories today

Open the live feed